신경 랩 시장 규모, 점유율, 동향 분석 리포트 : 수술별, 용도별, 지역별, 부문 예측(2025-2030년)

Nerve Wrap Market Size, Share & Trends Analysis Report By Surgery (Direct Nerve Repair, Nerve Grafting), By Application (Lower Extremities, Upper Extremities), By Region (North America, Asia Pacific), And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,635,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,087,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,990,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

신경 랩 시장 규모와 동향 :

세계의 신경 랩 시장 규모는 2024년에 1억 9,831만 달러로 추계되며, 2025-2030년에 CAGR 9.13%로 성장할 것으로 예측됩니다.

이 시장 성장의 주요 요인은 말초신경손상(PNI)의 유병률 증가와 신경치료를 위한 첨단 수술 솔루션의 채택이 증가하고 있기 때문입니다.

신경 랩은 흉터 조직의 형성을 방지하고 수술 후 최적의 신경 재생을 촉진하기 위해 자주 사용되고 있습니다. Barrow Neurology Institute에 따르면 PNI의 대부분은 상지, 특히 손목과 손에 발생하며, 신경 랩은 환자의 예후를 개선하는 임상적 효과를 입증했습니다. 의료 서비스 프로바이더가 최소 침습적이고 효과적인 신경 복구 전략을 우선시함에 따라 신경 랩에 대한 수요는 예측 기간 중 꾸준히 증가할 것으로 예측됩니다.

외상, 수술, 수근관 증후군과 같은 신경 압박 증후군 증가로 인해 신경 랩과 같은 신경 보호 및 재생 솔루션에 대한 수요가 크게 증가하고 있습니다. 미국 국립보건원(NIH)이 발표한 보고서에 따르면 2022년 10월 전 세계 인구의 약 2.4%가 말초신경장애를 앓고 있으며, 노년층에서는 유병률이 8%로 증가할 것으로 예상했습니다. 또한 2023년 8월 NIH의 보고에 따르면 신경압박증후군은 일반 인구에서 흔히 보고되는 병태이며, 심각도는 경미한 불편감에서 심각한 장애에 이르기까지 다양합니다.

당뇨병과 같은 만성질환은 신경 손상의 주요 원인이며, 종종 신경 장애를 유발합니다. 당뇨병, 특히 2형 당뇨병의 전 세계 유병률 증가는 신경 회복 및 보호 솔루션에 대한 수요 증가와 직접적인 상관관계가 있습니다. 클리블랜드 클리닉에 따르면 제 2형 당뇨병은 가장 흔한 당뇨병으로 당뇨병 환자의 90 - 95%를 차지하여 신경 랩 시장의 성장을 주도하고 있습니다.

감염 위험 감소, 빠른 회복, 수술 후 통증 감소 등의 장점으로 인해 말초신경 수복술에서 최소침습적 수술법이 점점 더 선호되고 있습니다. 신경 랩은 수복된 신경을 덮고, 긴장을 완화하고, 흉터 조직 형성을 억제함으로써 이러한 과정을 강화하여 기능 회복을 촉진하고 장기적인 결과를 얻을 수 있도록 합니다. 이러한 발전으로 보다 안전하고 효과적인 수술이 가능해져 임상 현장에서 신경 랩의 적용이 확대되고 있습니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 세계의 신경 랩 시장의 변수, 동향, 범위

• 시장 계통 전망
  • 모시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 세계 신경 랩 시장 분석 툴
  • 업계 분석 - Porter의 산업 분석
  • PESTEL 분석
  • 가격 분석
  • 파이프라인 분석

제4장 세계의 신경 랩 시장 : 수술 추정·동향 분석

• 세계의 신경 랩 시장 : 대시보드
• 세계의 신경 랩 시장 : 변동 분석
• 세계의 신경 랩 시장 : 매출별
• 직접 신경 수복
• 신경 이식

제5장 세계의 신경 랩 시장 : 용도 추정·동향 분석

• 세계의 신경 랩 시장 : 대시보드
• 세계의 신경 랩 시장 : 변동 분석
• 세계의 신경 랩 시장 : 매출별
• 하지
• 상지

제6장 세계의 신경 랩 시장 : 수술, 용도, 최종 용도별 지역 추정·동향 분석

• 지역 대시보드
• 시장 규모와 예측 동향 분석, 2018-2030년
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제7장 경쟁 구도

• 주요 시장 참여 기업에 의한 최근 동향과 영향 분석
• 기업/경쟁 분류
• 벤더 구도
  • 주요 판매 대리점 및 채널 파트너 리스트
  • 주요 고객
  • 주요 기업의 시장 점유율 분석(2024년)
  • Axogen Corporation
  • Stryker
  • Polyganics BV
  • Integra LifeSciences Corporation.
  • Newrotex
  • AdvaCare Pharma
  • Orthocell Ltd
  • BioCircuit Technologies

KSA

영문 목차

영문목차

Nerve Wrap Market Size & Trends:

The global nerve wrap market size was estimated at USD 198.31 million in 2024 and is projected to grow at a CAGR of 9.13% from 2025 to 2030. This market growth is largely attributed to the increasing prevalence of peripheral nerve injuries (PNIs) and the rising adoption of advanced surgical solutions for nerve repair.

Nerve wraps are increasingly used to prevent scar tissue formation and to promote optimal nerve regeneration post-surgery. According to Barrow Neurological Institute, most PNIs occur in the upper extremities, particularly the wrists and hands, where nerve wraps have demonstrated clinical efficacy in improving patient outcomes. As healthcare providers prioritize minimally invasive and effective nerve repair strategies, the demand for nerve wraps is expected to rise steadily throughout the forecast period.

The growing number of traumatic injuries, surgical procedures, and nerve compression syndromes, such as carpal tunnel syndrome, has significantly increased the demand for nerve protection and regeneration solutions such as nerve wraps. According to a report published by the National Institutes of Health (NIH), in October 2022, approximately 2.4% of the global population is affected by peripheral nerve disorders, with the prevalence rising to 8% among older adults. Moreover, according to a report by NIH in August 2023, nerve compression syndrome is a commonly reported condition in the general population, with severity ranging from mild discomfort to severe impairment.

Chronic conditions such as diabetes are major contributors to nerve damage, often resulting in neuropathy. The global rise in diabetes prevalence, particularly type 2 diabetes, is directly correlated with an increasing demand for nerve repair and protective solutions. As per the Cleveland Clinic, Type 2 diabetes is the most common form, representing 90% to 95% of all diabetes cases, driving the nerve wrap market growth.

Minimally invasive surgical methods are increasingly preferred in peripheral nerve repair because of advantages such as reduced infection risk, faster recovery, and lower postoperative pain. Nerve wraps enhance these processes by covering the repaired nerve, lessening tension, and inhibiting scar tissue formation, resulting in enhanced functional recovery and long-term results. These advancements enhance safer and more effective surgeries and encourage broader nerve wrap application in clinical settings.

Global Nerve Wrap Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2025 to 2030. For this study, Grand View Research has segmented the global nerve wrap market report based on surgery, application, and region.

• Surgery Outlook (Revenue, USD Million, 2025 - 2030)
• Direct Nerve Repair
• Nerve Grafting
• Application Outlook (Revenue, USD Million, 2025 - 2030)
• Lower Extremities
• Upper Extremities
• Regional Outlook (Revenue, USD Million, 2025 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • Kuwait
  • UAE

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Surgery
  • 1.2.2. Application
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Surgery and Application outlook
  • 2.2.2. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Global Nerve Wrap Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Global Nerve Wrap Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Pricing Analysis
  • 3.3.4. Pipeline Analysis

Chapter 4. Global Nerve Wrap Market: Surgery Estimates & Trend Analysis

• 4.1. Global Nerve Wrap Market: Surgery Dashboard
• 4.2. Global Nerve Wrap Market: Surgery Movement Analysis
• 4.3. Global Nerve Wrap Market by Surgery, Revenue
• 4.4. Direct Nerve Repair
  • 4.4.1. Direct nerve repair market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Nerve Grafting
  • 4.5.1. Nerve grafting market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Nerve Wrap Market: Application Estimates & Trend Analysis

• 5.1. Global Nerve Wrap Market: Application Dashboard
• 5.2. Global Nerve Wrap Market: Application Movement Analysis
• 5.3. Global Nerve Wrap Market by Application, Revenue
• 5.4. Lower Extremities
  • 5.4.1. Lower extremities market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Upper Extremities
  • 5.5.1. Upper extremities market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Nerve Wrap Market: Regional Estimates & Trend Analysis by Surgery, Application, and End Use

• 6.1. Regional Dashboard
• 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 6.3. North America
  • 6.3.1. U.S.
    • 6.3.1.1. Key country dynamics
    • 6.3.1.2. Regulatory framework/ reimbursement structure
    • 6.3.1.3. Competitive scenario
    • 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.2. Canada
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Regulatory framework/ reimbursement structure
    • 6.3.2.3. Competitive scenario
    • 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.3. Mexico
    • 6.3.3.1. Key country dynamics
    • 6.3.3.2. Regulatory framework/ reimbursement structure
    • 6.3.3.3. Competitive scenario
    • 6.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 6.4. Europe
  • 6.4.1. UK
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Regulatory framework/ reimbursement structure
    • 6.4.1.3. Competitive scenario
    • 6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Germany
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework/ reimbursement structure
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. France
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework/ reimbursement structure
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.4. Italy
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Regulatory framework/ reimbursement structure
    • 6.4.4.3. Competitive scenario
    • 6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.5. Spain
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Regulatory framework/ reimbursement structure
    • 6.4.5.3. Competitive scenario
    • 6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.6. Norway
    • 6.4.6.1. Key country dynamics
    • 61.4.6.2. Regulatory framework/ reimbursement structure
    • 6.4.6.3. Competitive scenario
    • 6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.7. Sweden
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Regulatory framework/ reimbursement structure
    • 6.4.7.3. Competitive scenario
    • 6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.8. Denmark
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Regulatory framework/ reimbursement structure
    • 6.4.8.3. Competitive scenario
    • 6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Japan
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework/ reimbursement structure
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.2. China
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.3. India
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework/ reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.4. Australia
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework/ reimbursement structure
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.5. South Korea
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework/ reimbursement structure
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.6. Thailand
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework/ reimbursement structure
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Latin America
  • 6.6.1. Brazil
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework/ reimbursement structure
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.2. Argentina
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. MEA
  • 6.7.1. South Africa
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework/ reimbursement structure
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.2. Saudi Arabia
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.3. UAE
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ reimbursement structure
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.4. Kuwait
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ reimbursement structure
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2024
  • 7.3.4. Axogen Corporation
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Surgery benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Stryker
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Surgery benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Polyganics BV
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Surgery benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Integra LifeSciences Corporation.
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Surgery benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Newrotex
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Surgery benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. AdvaCare Pharma
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Surgery benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Orthocell Ltd
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Surgery benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. BioCircuit Technologies
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Surgery benchmarking
    • 7.3.11.4. Strategic initiatives

관련자료